Evotec Q2 EPS $(0.04) Misses $(0.04) Estimate, Sales $185.59M Miss $194.36M Estimate
Portfolio Pulse from Benzinga Newsdesk
Evotec (NASDAQ:EVO) reported Q2 losses of $(0.04) per share, missing the analyst consensus estimate by 7.5%. The company also reported quarterly sales of $185.59 million, missing the analyst consensus estimate of $194.36 million by 4.51%. Despite the misses, these figures represent an increase over the same period last year.
August 29, 2023 | 6:42 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Evotec's Q2 earnings and sales missed analyst estimates, which could negatively impact the stock in the short term. However, the results are an improvement over the same period last year.
Evotec's Q2 earnings and sales missed analyst estimates, which could lead to a decrease in investor confidence and a potential drop in the stock price. However, the fact that these figures represent an improvement over the same period last year could mitigate some of this negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100